ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Prevalence of Donor Specific Antibody in Heart Transplant Recipients with Antibody-Mediated Rejection as Compared to Abnormal Intragraft mRNA Transcripts by Molecular Microscope System

K. Shah, R. J. Levine, S. Dimbil, S. Sana, P. F. Halloran, J. Patel, D. H. Chang, E. Kransdorf, M. Kittleson, J. A. Kobashigawa

Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

Meeting: 2019 American Transplant Congress

Abstract number: B94

Keywords: Heart, Rejection

Session Information

Date: Sunday, June 2, 2019

Session Name: Poster Session B: Heart and VADs: All Topics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Development and Validation of a Molecular Microscope Diagnostic System (MMDx) for Heart Transplant Biopsies.
  • A New Diagnostic Tool for Antibody Mediated Rejection in Heart and Lung Transplantation: Intragraft Donor Specific Anti-HLA Antibodies Detection

*Purpose: Antibody-mediated rejection (AMR) is defined by pathologic evaluation of endomyocardial biopsy (EMB) for both histologic and immunopathologic components. Detectable donor specific antibodies (DSAs) in the setting of acute AMR are not always present. This may be related to variable interpretations of AMR by pathologists. The INTERHEART study evaluated for mRNA transcripts via the molecular microscope (MMDx) to assess for T cell-mediated (TCMR) and antibody-mediated (ABMR) rejection. We retrospectively evaluated the presence of detectable DSA in heart transplant (HTx) recipients with AMR as compared to those with ABMR by MMDx.

*Methods: Between 2016 and 2018, 72 HTx EMB samples were evaluated by pathology and MMDx. Significant DSA was defined as detectable within 1 month of EMB with mean fluorescence intensity (MFI) greater than 5,000.

*Results: In HTx recipients with AMR grade 1 or greater (n=17), 35.3% of patients had DSA as compared to patients with no evidence of AMR (n=50), 14% had DSA (p=NS). Conversely, in patients with abnormal MMDx concerning for ABMR (n=18), 44.4% of patients had DSA as compared to those with normal MMDx (n=44), 4.5% of patients had DSA (p<0.05). (Figure)

*Conclusions: In this small study of HTx recipients who undergo EMB for evaluation of rejection, patients with abnormal MMDx concerning for ABMR have a greater prevalence of detectable DSA greater than MFI of 5,000 as compared to those with normal MMDx. In patients with abnormal histology concerning for AMR, there is no detectable difference in DSA as compared to pathology interpretation as normal. The MMDx system may have a greater relationship with detectable DSA than histology interpretation for AMR and future studies should be conducted given the relationship of DSA to adverse outcomes.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Shah K, Levine RJ, Dimbil S, Sana S, Halloran PF, Patel J, Chang DH, Kransdorf E, Kittleson M, Kobashigawa JA. Prevalence of Donor Specific Antibody in Heart Transplant Recipients with Antibody-Mediated Rejection as Compared to Abnormal Intragraft mRNA Transcripts by Molecular Microscope System [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/prevalence-of-donor-specific-antibody-in-heart-transplant-recipients-with-antibody-mediated-rejection-as-compared-to-abnormal-intragraft-mrna-transcripts-by-molecular-microscope-system/. Accessed December 12, 2019.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Penis Transplantation: First U.S. Experience.
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    wiley-new-logo

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.